• 1
    Brown T, Qaqish R. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20: 21642174.
  • 2
    McComsey GA, Tebas P, Shane E et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Iinfect Dis 2010; 51: 937946.
  • 3
    Collin F, Duval X, Le Moing V et al. Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS 2009; 23: 10211024.
  • 4
    Womack J, Goulet J, Gibert C et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS ONE 2011; 6: e17217.
  • 5
    Mueller NJ, Fux CA, Ledergerber B et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24: 18.
  • 6
    Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 2010; 24: 223227.
  • 7
    Dao CN, Patel P, Overton ET et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a Cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52: 396405.
  • 8
    Cervero M, Agud J, García-Lacalle C et al. Prevalence of vitamin D deficiency and its related risk factor in a Spanish Cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2012; 28: 963971.
  • 9
    Adeyemi OM, Agniel D, French AL et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011; 57: 197204.
  • 10
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266281.
  • 11
    Overton E, Yin MT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 2011; 13: 8393.
  • 12
    Welz T, Childs K, Ibrahim F et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24: 19231928.
  • 13
    Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24: 13751382.
  • 14
    Brown TT, McComsey GA. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010; 15: 425429.
  • 15
    Wohl D, Doroara M, Pilotto JH et al. Change in Vitamin D levels smaller of development of severe Vitamin D Deficiency lower among HIV-1 infected, Treatment-naive adults receiving TMC278 compared with EFV: 48-weeks result from the Phase III ECHO trial [O].1014]. 18th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February-March 2011.
  • 16
    Fox J, Peters B, Prakash M et al. Improvement in vitamin D deficiency following antiretroviral regime changes: results from the MONET trial. AIDS Res Hum Retroviruses 2011; 27: 2934.
  • 17
    Kim J, Gandhi V, Psevdos G et al. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses 2012; 28: 235241.
  • 18
    Panel on Clinical. Practices for the treatment of HIV infection. Spanish Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Consensus document GESIDA and PNS on antiretroviral treatment in adults, December 29, 2010. Available at
  • 19
    Heaney RP, Dowell MS, Hale CA et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142146.
  • 20
    Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551561.
  • 21
    Clemens TL, Adams JS, Henderson SL et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 8263: 7476.
  • 22
    Rosenvinge MM, Gedela K, Copas AJ et al. Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010; 54: 496499.
  • 23
    Mehta S, Spiegelman D, Magusi F et al. Vitamin D HIV-related complications and HIV disease progression women in Tanzania. AIDS Patient Care STDS 2011; 25: 579585.
  • 24
    Terrier B, Carrat F, Geri G et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011; 55: 756761.
  • 25
    Cozzolino M, Vidal M, Arcidiacono MV et al. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003; 17: 513520.